Neuropeptidergic modulation of emotional states
Addiction vulnerability and resilience
The brain-body connection and emotion
To selectively probe the neuropeptidergic contribution to the circuit without affecting co-released neurotransmitters, we utilize a CRISPR-Cas9 mediated approach to manipulate neuropeptide gene expression and specifically monitor neuropeptide dynamics in vivo using genetically encoded fluorescent peptide-sensors.
See examples:
To precisely dissect neural circuits in behavior, we employ optogenetics, chemogenetics, and monosynaptic rabies tracing techniques.
See examples:
To reveal the functional role of neural circuits and the impact of neuromodulation, we perform in vivo electrophysiological recordings with both bundled electrodes and Neuropixels probes, as well as cellular resolution calcium imaging in freely-moving mice, in combination of optogenetics or CRISPR-Cas9 gene-editing.
See examples:
To study neuropsychiatric diseases in preclinical rodent models, we employ a wide range of behavioral assays, including Pavlovian conditioning, 3-cued discrimination task, reward-punishment conflict task, and cocaine self-administration. In addition, we aim to combine computer vision tools with unsupervised data-driven algorithms for the identification of nuanced behavioral motifs.
See examples:
To gain deeper mechanistic insight into neural activity and behavior, we use computational approaches, including unsupervised clustering, neural trajectory analysis, machine learning-based modeling, and real-time behavioral identification with close-loop stimulation (example videos using AlphaClass, unpublished work).
See examples:
